期刊
CYTOKINE & GROWTH FACTOR REVIEWS
卷 22, 期 1, 页码 45-53出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2010.09.004
关键词
Sphingosine 1-phosphate; Sphingosine kinase; Inflammation; Cytokines; Cell signaling
资金
- Australian National Heart Foundation
- Cancer Institute of NSW
- National Health and Medical Research Council of Australia
- Juvenile Diabetes Research Foundation (International)
Sphingosine 1-phosphate (S1P) is a sphingolipid metabolite, which has emerged as an important signaling mediator participating in the regulation of multiple cellular processes. The discovery of a family of SIP receptors, together with the more recently identified intracellular targets, has provided fundamental understanding of the multi-faceted actions of SIP. Evidence from both in vitro and in vivo studies has implicated the SIP signaling system in the control of immunity, inflammation and many associated diseases. Enigmatically, SIP appears to have both pro- and anti-inflammatory effects depending on the cell context. Here, we review this emerging area and argue for a pivotal role for SIP, as a key mediator of the cytokine network, acting through juxtacrine signaling in the immune system. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据